Severe hypertriglyceridaemia associated with the use of capecitabine

H. A. Polinder-Bos; E. E. Kok; A. van de Wiel; W. Spiering; J. P.M. Wielders; H. J. Bloemendal

Severe hypertriglyceridaemia associated with the use of capecitabine

H. A. Polinder-Bos
, E. E. Kok
, A. van de Wiel
, W. Spiering
, J. P.M. Wielders
, H. J. Bloemendal

Meander Medical Center
Utrecht University

Research output: Contribution to journal › Comment/Letter to the editor › Professional › peer-review

14 Citations (Scopus)

Abstract

Dear Editor,
Capecitabine is frequently used as adjuvant chemotherapy in colorectal cancer and in the treatment of advanced or metastatic breast, colorectal or gastric cancer. The main adverse effects of capecitabine are palmar-plantar erythrodysthesia, diarrhoea and stomatitis. Only a few cases of capecitabine-associated hypertriglyceridaemia have been documented.
[...]

Original language	English
Pages (from-to)	104
Number of pages	1
Journal	Netherlands Journal of Medicine
Volume	70
Issue number	2
Publication status	Published - Feb 2012
Externally published	Yes

Bibliographical note

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

https://www.njmonline.nl/article_ft.php?a=1157&d=748&i=146

Cite this

@article{a2640eda8647405592dab30a65cd1be8,

title = "Severe hypertriglyceridaemia associated with the use of capecitabine",

abstract = "Dear Editor, Capecitabine is frequently used as adjuvant chemotherapy in colorectal cancer and in the treatment of advanced or metastatic breast, colorectal or gastric cancer. The main adverse effects of capecitabine are palmar-plantar erythrodysthesia, diarrhoea and stomatitis. Only a few cases of capecitabine-associated hypertriglyceridaemia have been documented. [...] ",

author = "Polinder-Bos, \{H. A.\} and Kok, \{E. E.\} and \{van de Wiel\}, A. and W. Spiering and Wielders, \{J. P.M.\} and Bloemendal, \{H. J.\}",

year = "2012",

month = feb,

language = "English",

volume = "70",

pages = "104",

journal = "Netherlands Journal of Medicine",

issn = "0300-2977",

number = "2",

}

TY - JOUR

T1 - Severe hypertriglyceridaemia associated with the use of capecitabine

AU - Polinder-Bos, H. A.

AU - Kok, E. E.

AU - van de Wiel, A.

AU - Spiering, W.

AU - Wielders, J. P.M.

AU - Bloemendal, H. J.

PY - 2012/2

Y1 - 2012/2

N2 - Dear Editor, Capecitabine is frequently used as adjuvant chemotherapy in colorectal cancer and in the treatment of advanced or metastatic breast, colorectal or gastric cancer. The main adverse effects of capecitabine are palmar-plantar erythrodysthesia, diarrhoea and stomatitis. Only a few cases of capecitabine-associated hypertriglyceridaemia have been documented. [...]

AB - Dear Editor, Capecitabine is frequently used as adjuvant chemotherapy in colorectal cancer and in the treatment of advanced or metastatic breast, colorectal or gastric cancer. The main adverse effects of capecitabine are palmar-plantar erythrodysthesia, diarrhoea and stomatitis. Only a few cases of capecitabine-associated hypertriglyceridaemia have been documented. [...]

UR - https://www.scopus.com/pages/publications/84858600572

M3 - Comment/Letter to the editor

C2 - 22418760

AN - SCOPUS:84858600572

SN - 0300-2977

VL - 70

SP - 104

JO - Netherlands Journal of Medicine

JF - Netherlands Journal of Medicine

IS - 2

ER -

Severe hypertriglyceridaemia associated with the use of capecitabine

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this